Abstract:By taking advantage of the genetic engineering approach and homology of leukocytes, a single‐chain variable fragment of anti‐EGFR antibody is overexpressed on the Jurkat cell membrane. Then, the authors one‐step construct cell membrane‐coated magnetic nanoparticles for isolation of circulating tumor cells. The resulting nanoparticles achieve highly efficient and highly specific isolation of circulating tumor cells in artificial and clinical samples. Circulating tumor cells (CTCs) are a crucial biomarker for early cancer diagnosis and progress of cancer metastasis. However, the extremely rare CTCs with large amounts of background leukocytes seriously restricte the purity of enriched CTCs. Herein, genetically engineered cell membrane‐coated magnetic nanoparticles with following properties are constructed: I) The leukocyte membrane camouflaged nanoparticles, which could significantly reduce nonspecific binding of homologous leukocytes and achieve high‐purity isolation of CTCs, are prepared by simple one‐step extrusion and II) the cellular membrane stably expressing single‐chain variable fragment (scFv) of anti‐epidermal growth factor receptor (EGFR) antibody could ensure the recognition of EGFR‐positive CTCs. The binding affinity of the resulting nanoparticles toward extracellular EGFR protein improved more than 100‐fold compared with natural cell membrane‐coated nanoparticles. Furthermore, compared with commercial immunomagnetic nanoparticles, the functional nanoparticles achieved a greater capture efficiency in artificial blood samples and the cell purity increased from 64.8% to 93.5%. Consequently, the authors successfully isolate high pure CTCs from 6 out of 6 cancer patients using engineered cell membrane‐coated nanoparticles. This platform exhibits a promising potential for CTC detection in clinical samples, offering an innovative method for cancer diagnosis and prognosis evaluation.

Ex vivo expansion of circulating lung tumor cells based on one-step microfluidics-based immunomagnetic isolation.

Isolation and characterization of living circulating tumor cells in patients by immunomagnetic negative enrichment coupled with flow cytometry.

Fast Isolation and Ex Vivo Culture of Circulating Tumor Cells from the Peripheral Blood of Lung Cancer Patients.

Short-Term Ex Vivo Culture of CTCs from Advance Breast Cancer Patients: Clinical Implications

Design and Clinical Application of an Integrated Microfluidic Device for Circulating Tumor Cells Isolation and Single-Cell Analysis

Self-Sterilizing and Regeneratable Microchip for the Precise Capture and Recovery of Viable Circulating Tumor Cells from Patients with Cancer.

Expansion of CTCs from Early Stage Lung Cancer Patients Using a Microfluidic Co-Culture Model.

Isolation of circulating tumor cells in non-small-cell-lung-cancer patients using a multi-flow microfluidic channel

Development and clinical validation of a microfluidic-based platform for CTC enrichment and downstream molecular analysis

Efficient Separation of Tumor Cells from Untreated Whole Blood Using a Novel Multistage Hydrodynamic Focusing Microfluidics.

Clinical test on circulating tumor cells in peripheral blood of lung cancer patients, based on novel immunomagnetic beads

Enrichment and separation technology for evaluation of circulating tumor cells

Hybrid magnetic and deformability based isolation of circulating tumor cells using microfluidics

Novel Isolating Approaches to Circulating Tumor Cell Enrichment Based on Microfluidics: A Review

Isolation and mutational analysis of circulating tumor cells from lung cancer patients with magnetic sifters and biochips

An Integrated Microfluidic Chip System for Single-Cell Secretion Profiling of Rare Circulating Tumor Cells

A novel microfluidic system for enrichment of functional circulating tumor cells in cancer patient blood samples by combining cell size and invasiveness

Enhanced Separation Efficiency and Purity of Circulating Tumor Cells Based on the Combined Effects of Double Sheath Fluids and Inertial Focusing

Detection of Circulating Tumor Cells Using a Novel Immunomagnetic Bead Method in Lung Cancer Patients

Genetically Engineered Cell Membrane‐Coated Magnetic Nanoparticles for High‐Performance Isolation of Circulating Tumor Cells

Label-Free Isolation and mRNA Detection of Circulating Tumor Cells from Patients with Metastatic Lung Cancer for Disease Diagnosis and Monitoring Therapeutic Efficacy